Guanine nucleotides regulate sphingosine kinase 1 activation by eukaryotic elongation factor 1A and provide a mechanism for eEF1A-associated oncogenesis.
Sphingosine kinase 1 (SK1) catalyses the formation of bioactive phospholipid sphingosine 1-phosphate (S1P). Elevated cellular SK1 activity and S1P levels enhance cell proliferation and survival, and are strongly implicated in tumourigenesis. Regulation of SK1 activity can occur through various mechanisms, including phosphorylation and protein-protein interactions. We have previously shown that eukaryotic elongation factor 1A (eEF1A) interacts with and directly activates SK1, but the mechanisms regulating this were undefined. Notably, eEF1A has GTPase activity and can exist in GTP- or GDP-bound forms, which are associated with distinct structural conformations of the protein. Here, we show that the guanine nucleotide-bound state of eEF1A regulates its ability to activate SK1, with eEF1A.GDP, but not eEF1A.GTP, enhancing SK1 activity in vitro. Furthermore, we show that enhancing cellular eEF1A.GDP levels through expression of a guanine nucleotide dissociation inhibitor of eEF1A, translationally controlled tumour protein (TCTP), increased SK1 activity in cells. We also examined a truncated isoform of eEF1A1, termed prostate tumour inducer-1 (PTI-1), which can induce neoplastic cell transformation through undefined mechanisms. PTI-1 lacks the G protein domain of eEF1A1 and is therefore unable to undergo the GTP-binding-induced conformational change. Notably, we found that PTI-1 can directly activate SK1 and that this seems to be essential for neoplastic transformation induced by PTI-1, as chemical SK1 inhibitors or overexpression of a dominant-negative SK1 blocked this process. Thus, this study defines the mechanism regulating eEF1A-mediated SK1 activation, and also establishes SK1 as being integral for PTI-1-induced oncogenesis.
Leclercq
T M
TM
Molecular Signalling Laboratory, Centre for Cancer Biology, SA Pathology, Adelaide, South Australia, Australia.
Moretti
P A B
PA
Pitson
S M
SM
D000818:Animals; D001483:Base Sequence; D016466:CHO Cells; D002471:Cell Transformation, Neoplastic; D006224:Cricetinae; D003412:Cricetulus; D017931:DNA Primers; D004789:Enzyme Activation; D006150:Guanine Nucleotides / Q000502:physiology*; D006801:Humans; D020648:Peptide Elongation Factor 1 / Q000502:physiology*; D017853:Phosphotransferases (Alcohol Group Acceptor) / Q000378:metabolism*; D000090324:Tumor Protein, Translationally-Controlled 1; D000099157:Sphingosine Kinase
D017931:DNA Primers; D006150:Guanine Nucleotides; D020648:Peptide Elongation Factor 1; D017853:Phosphotransferases (Alcohol Group Acceptor); D000090324:Tumor Protein, Translationally-Controlled 1; D000099157:Sphingosine Kinase; C094814:EEF1A1 protein, human; C000715647:TPT1 protein, human